These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17414063)

  • 21. Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
    Flombaum CD; Mouradian JA; Casper ES; Erlandson RA; Benedetti F
    Am J Kidney Dis; 1999 Mar; 33(3):555-62. PubMed ID: 10070921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Is the frequency of hemolytic uremic syndrome as a complication of gemcitabine underestimated? The role of systematic screening].
    Desramé J; Duvic C; Béchade D; Bredin C; Raynaud JJ; Defuentes G; Dourthe LM; Algayres JP
    Gastroenterol Clin Biol; 2006 Feb; 30(2):332-4. PubMed ID: 16565677
    [No Abstract]   [Full Text] [Related]  

  • 23. Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone.
    Geffen DB; Horowitz J
    Isr Med Assoc J; 2000 Jul; 2(7):552-3. PubMed ID: 10979335
    [No Abstract]   [Full Text] [Related]  

  • 24. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
    Rocha Lima CM; Flores AM
    J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
    [No Abstract]   [Full Text] [Related]  

  • 25. [IMRD therapy for patients with metastatic pancreas cancer].
    Yamashita K; Takahashi Y
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():219-22. PubMed ID: 16457254
    [No Abstract]   [Full Text] [Related]  

  • 26. Gemcitabine-induced myositis in a diabetes mellitus patient on hemodialysis.
    Chun JY; Lee JM; Ahn DW; Chai JW; Kim YA; Shin K
    Korean J Intern Med; 2017 Sep; 32(5):930-932. PubMed ID: 26922072
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of progressive hypertension preceding gemcitabine-associated thrombotic microangiopathy complicated by acute kidney injury and stroke.
    Phelan PJ; Liew A; Magee C
    Ren Fail; 2009; 31(8):743-4. PubMed ID: 19814643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.
    Lhotta K; Kühr T; Rumpelt HJ; Wöll E; Thaler J; König P
    Am J Nephrol; 1999; 19(5):590-3. PubMed ID: 10575189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
    Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
    Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer].
    Wato M; Inaba T; Ishikawa H; Ishikawa S; Baba N; Miyoshi M; Senoh T; Nagano T; Takaguchi K; Watanabe S; Kawai K
    Nihon Shokakibyo Gakkai Zasshi; 2010 Oct; 107(10):1676-85. PubMed ID: 20938119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
    Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
    J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer.
    Yamauchi J; Kanai M; Matsumoto S; Nishimura T; Yazumi S; Kami K; Kawaguchi Y; Yasuda H; Kitano T; Misawa A; Ishiguro H; Yoshikawa K; Yanagihara K; Fukushima M; Doi R; Chiba T
    Pancreas; 2008 Apr; 36(3):327-8. PubMed ID: 18362852
    [No Abstract]   [Full Text] [Related]  

  • 33. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
    Katagiri D; Hinoshita F
    CEN Case Rep; 2018 Nov; 7(2):217-220. PubMed ID: 29766468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of drug-induced interstitial pneumonitis after gemcitabine treatment for advanced pancreatic cancer].
    Nomura M; Inoue Y; Fujita S; Sakao J; Hirota M; Souda S
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):123-7. PubMed ID: 16410712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients.
    Ueno H; Kaniwa N; Okusaka T; Ikeda M; Morizane C; Kondo S; Sugiyama E; Kim SR; Hasegawa R; Saito Y; Yoshida T; Saijo N; Sawada J
    Br J Cancer; 2009 Mar; 100(6):870-3. PubMed ID: 19293806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.
    Tamiya A; Endo M; Shukuya T; Igawa S; Tsuya A; Nakamura Y; Murakami H; Takahashi T; Boku N; Yamamoto N
    Pancreas; 2009 Oct; 38(7):838-40. PubMed ID: 19893461
    [No Abstract]   [Full Text] [Related]  

  • 37. Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer.
    Cao Y; Wu L; Tan A; Liu L; Liao C; Gao F
    Pancreas; 2010 Mar; 39(2):253-5. PubMed ID: 20182311
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pancreatic carcinoma: progress in therapy].
    Lordick F
    Krankenpfl J; 2004; 42(5-6):158-9. PubMed ID: 15527223
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS).
    Assi C; Lepage C; Jouve JL; Sgro C; Bedenne L
    Gastroenterol Clin Biol; 2010 Nov; 34(11):640-2. PubMed ID: 21051168
    [No Abstract]   [Full Text] [Related]  

  • 40. Gemcitabine-induced chronic systemic capillary leak syndrome.
    Bajwa R; Starr J; Daily K
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28855215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.